Countries where authors publish in Molecular Cancer Therapeutics
Since Specialization
Citations
This map shows the geographic impact of research published in Molecular Cancer Therapeutics. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Molecular Cancer Therapeutics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molecular Cancer Therapeutics more than expected).
Fields of papers published in Molecular Cancer Therapeutics
This network shows the impact of papers published in Molecular Cancer Therapeutics. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Molecular Cancer Therapeutics.
About Molecular Cancer Therapeutics
The 6.8k papers published in Molecular Cancer Therapeutics in the last decades have received a total of 290.0k indexed citations . Papers published in Molecular Cancer Therapeutics usually cover Oncology (3.0k papers), Cancer Research (1.3k papers), Molecular Biology (4.1k papers), Pulmonary and Respiratory Medicine (1.1k papers) and Genetics (366 papers) specifically the topics of Cancer-related Molecular Pathways (645 papers), Cancer, Hypoxia, and Metabolism (487 papers), PI3K/AKT/mTOR signaling in cancer (470 papers), Monoclonal and Polyclonal Antibodies Research (469 papers), HER2/EGFR in Cancer Research (444 papers), Lung Cancer Treatments and Mutations (400 papers), Cell death mechanisms and regulation (377 papers) and Ubiquitin and proteasome pathways (371 papers). The most active scholars publishing in Molecular Cancer Therapeutics are Razelle Kurzrock, Sandip Pravin Patel, Edith A. Perez, Daniel D. Von Hoff, Garth Powis, Frank A. Sinicrope, Takumi Kawabe, Yves Pommier, Santosh K. Katiyar and Shengbing Huang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.